leflunomide has been researched along with Carcinoma, Pancreatic Ductal in 1 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
Carcinoma, Pancreatic Ductal: Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, M | 1 |
| Nguyen, ND | 1 |
| Huang, Y | 1 |
| Lin, D | 1 |
| Fujimoto, TN | 1 |
| Molkentine, JM | 1 |
| Deorukhkar, A | 1 |
| Kang, Y | 1 |
| San Lucas, FA | 1 |
| Fernandes, CJ | 1 |
| Koay, EJ | 1 |
| Gupta, S | 1 |
| Ying, H | 1 |
| Koong, AC | 1 |
| Herman, JM | 1 |
| Fleming, JB | 1 |
| Maitra, A | 1 |
| Taniguchi, CM | 1 |
1 other study available for leflunomide and Carcinoma, Pancreatic Ductal
| Article | Year |
|---|---|
Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer.
Topics: Animals; Carcinoma, Pancreatic Ductal; CRISPR-Cas Systems; Disease Models, Animal; Dynamins; Enzyme | 2019 |